Prenatal Caffeine Assessment: Fetal and Maternal Biomarkers or Self-Reported Intake?

Annals of Epidemiology

Volumn 18, Issue 3, 2008, Pages 172-178

  Grosso, Laura M ^a   Triche, Elizabeth ^a   Benowitz, Neal L ^b   Bracken, Michael B ^a  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarkers; Caffeine; Cord Blood; Pregnancy; Self Report

Indexed keywords

BIOLOGICAL MARKER; CAFFEINE; PARAXANTHINE; THEOBROMINE; THEOPHYLLINE;

ADULT; ARTICLE; DIETARY INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; SELF REPORT; UMBILICAL CORD BLOOD; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; CAFFEINE; CONNECTICUT; FEMALE; FETAL BLOOD; HUMANS; MASSACHUSETTS; MATERNAL-FETAL EXCHANGE; MOTHERS; PREGNANCY; PREGNANCY OUTCOME;

EID: 39149142523     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2007.11.005     Document Type: Article

References (14)

1. Frary C., Johnson R., and Wang M. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Dietetic Assoc 105 (2005) 110-113
2. Grosso L., and Bracken M.B. Caffeine metabolism, genetics, and perinatal outcomes: A review of exposure assessment considerations during pregnancy. Ann Epidemiol 15 (2005) 460-466
3. Bracken M., Triche E., Grosso L., Hellenbrand K., Belanger K., and Leaderer B. Heterogeneity in assessing self-reports of caffeine exposure: Implications for studies of health effects. Epidemiology 13 (2002) 165-171
4. Aldridge A., Bailey J., and Neims A. The disposition of caffeine during and after pregnancy. Semin Perinatol 5 (1981) 310-314
5. Kalow W., and Tang B.-K. Caffeine as a metabolic probe: Exploration of the enzyme-inducing effect of cigarette smoking. Clin Pharmacol Ther 49 (1991) 44-48
6. Parsons W., and Neims A. Effect of smoking on caffeine clearance. Clin Pharmacol Ther 24 (1978) 734-739
7. Abernethy D., and Todd E. Impairment of caffeine clearance by chronic use of low-dose estrogen-containing oral contraceptives. Eur J Clin Pharmacol 28 (1985) 425-428
8. Patwardhan R., Desmond P., Johnson R., and Schenker S. Impaired elimination of caffeine by oral contraceptive steroid. J Lab Clin Med 95 (1980) 603-608
9. Arnaud M. Metabolism of Caffeine and Other Components of Coffee (1993), Raven Press, New York
10. Carrillo J., and Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 39 (2000) 127-153
11. Tsutsumi K., Kotegawa T., Matsuki S., et al. The effect of pregnancy on cytochrome p4501a2, xanthine oxidase, and n-acetyltransferase activities in humans. Clin Pharmacol Ther 70 (2001) 121-125
12. Bunker M., and McWilliams M. Caffeine content of common beverages. J Am Dietetic Assoc 74 (1979) 28-31
13. Klebanoff M., Levine R., DerSimonian R., Clemens J., and Wilkins D. Serum caffeine and paraxanthine as markers for reported caffeine intake in pregnancy. Ann Epidemiol 8 (1998) 107-111
14. Rostami-Hodjegan A., Nurminen S., Jackson P., and Tucker G. Caffeine urinary metabolite ratios as markers of enzyme activity: A theoretical assessment. Pharmacogenetics 6 (1996) 121-149